Subsidiary Guarantors Condensed Consolidating Statement of Cash Flows (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 02, 2016	Jul. 04, 2015
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	$ (30,144)	$ (38,679)
Investing Activities
Capital expenditures	(3,955)	(9,901)
Proceeds from the sale of assets	111	8
Payments on loans to affiliates	0	0
Receipts on loans to affiliates	0	0
Net cash used in investing activities	(3,844)	(9,893)
Financing Activities
Borrowings under ABL facilities	103,289	99,731
Payments under ABL facilities	(96,149)	(53,053)
Proceeds from promissory note	27,500	0
Financing fees	(2,226)	0
Borrowings from affiliates	0	0
Repayments to affiliates		0
Net cash provided by financing activities	32,414	46,678
Effect of exchange rate changes on cash and cash equivalents	33	(40)
Net (decrease) increase in cash and cash equivalents	(1,541)	(1,934)
Cash and cash equivalents at beginning of period	9,394	5,963
Cash and cash equivalents at end of period	7,853	4,029
Company
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(23,656)	(33,721)
Investing Activities
Capital expenditures	(2,430)	(8,731)
Proceeds from the sale of assets	107	7
Payments on loans to affiliates	0	0
Receipts on loans to affiliates	0	2,000
Net cash used in investing activities	(2,323)	(6,724)
Financing Activities
Borrowings under ABL facilities	55,500	48,200
Payments under ABL facilities	(62,400)	(34,700)
Proceeds from promissory note	20,000
Financing fees	(2,216)
Borrowings from affiliates	14,211	31,706
Repayments to affiliates		(7,500)
Net cash provided by financing activities	25,095	37,706
Effect of exchange rate changes on cash and cash equivalents	0	0
Net (decrease) increase in cash and cash equivalents	(884)	(2,739)
Cash and cash equivalents at beginning of period	8,356	5,933
Cash and cash equivalents at end of period	7,472	3,194
Co-Issuer
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Investing Activities
Capital expenditures	0	0
Proceeds from the sale of assets	0	0
Payments on loans to affiliates	0	0
Receipts on loans to affiliates	0	0
Net cash used in investing activities	0	0
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Proceeds from promissory note	0
Financing fees	0
Borrowings from affiliates	0	0
Net cash provided by financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net (decrease) increase in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	7,633	6,787
Investing Activities
Capital expenditures	(74)	(81)
Proceeds from the sale of assets	0	0
Payments on loans to affiliates	(7,711)	(6,706)
Receipts on loans to affiliates	0	0
Net cash used in investing activities	(7,785)	(6,787)
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Proceeds from promissory note	0
Financing fees	0
Borrowings from affiliates	0	0
Net cash provided by financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net (decrease) increase in cash and cash equivalents	(152)	0
Cash and cash equivalents at beginning of period	152	0
Cash and cash equivalents at end of period	0	0
Non-Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(14,121)	(11,745)
Investing Activities
Capital expenditures	(1,451)	(1,089)
Proceeds from the sale of assets	4	1
Payments on loans to affiliates	0	(25,000)
Receipts on loans to affiliates	(6,500)	7,500
Net cash used in investing activities	(7,947)	(18,588)
Financing Activities
Borrowings under ABL facilities	47,789	51,531
Payments under ABL facilities	(33,749)	(18,353)
Proceeds from promissory note	7,500
Financing fees	(10)
Borrowings from affiliates	0	0
Repayments to affiliates		(2,000)
Net cash provided by financing activities	21,530	31,178
Effect of exchange rate changes on cash and cash equivalents	33	(40)
Net (decrease) increase in cash and cash equivalents	(505)	805
Cash and cash equivalents at beginning of period	886	30
Cash and cash equivalents at end of period	381	835
Reclassification/ Eliminations
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Investing Activities
Capital expenditures	0	0
Proceeds from the sale of assets	0	0
Payments on loans to affiliates	7,711	31,706
Receipts on loans to affiliates	6,500	(9,500)
Net cash used in investing activities	14,211	22,206
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Proceeds from promissory note	0
Financing fees	0
Borrowings from affiliates	(14,211)	(31,706)
Repayments to affiliates		9,500
Net cash provided by financing activities	(14,211)	(22,206)
Effect of exchange rate changes on cash and cash equivalents	0	0
Net (decrease) increase in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	$ 0	$ 0